Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal study.
Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal study.
复制标题
中国武汉市 COVID-19 幸存者临床后遗症的一些特征:多中心纵向研究
DOI:
10.1111/irv.12943
复制
发表时间:
2022-05
影响因子:
4.4
通讯作者:
Cen Y
中科院分区:
文献类型:
--
作者:
Chen X;Li Y;Shao TR;Yang LL;Li SJ;Wang XJ;Li A;Wu YY;Liu XF;Liu CM;Liu YH;Zeng F;Cen Y
The pandemic of COVID‐19 has a persistent impact on global health, yet its sequelae need to be addressed at a wide scale around the globe. This study aims to investigate the characteristics, prevalence, and risk factors for mid‐term (>6 months) clinical sequelae in a cohort of COVID‐19 survivors. Totally 715 COVID‐19 survivors discharged before April 1, 2020, from three medical centers in Wuhan, China, were included. The longitudinal study was conducted by telephone interviews based on a questionnaire including the clinical sequelae of general, respiratory, and cardiovascular systems. Demographics and some characteristics of clinical sequelae of the survivors were recorded and analyzed. Multivariate logistic regression analysis was applied to explore the risk factors for the sequelae. The median time interval from discharge to telephone interview was 225.0 days. The COVID‐19 survivors' median ages were 69 years, and 51.3% were male. Among them, 29.9% had at least one clinical sequela. There were 19.2%, 22.7%, and 5.0% of the survivors reporting fatigue, respiratory symptoms, and cardiovascular symptoms, respectively. Comorbidities, disease severity, the application of mechanical ventilation and high‐flow oxygen therapy, and the history of re‐admission were associated with the presence of clinical sequelae. Our study provides further evidence for the prevalence and characteristics of clinical sequelae of COVID‐19 survivors, suggesting long‐term monitoring and management is needed for their full recovery.
登录
查看更多内容
DOI:
10.15557/pimr.2020.0003
发表时间:
2020-01-01
影响因子:
3.6
作者:
通讯作者:
--
DOI:
10.1016/j.cmi.2020.09.023
发表时间:
2021-01
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
作者:
Xiong Q;Xu M;Li J;Liu Y;Zhang J;Xu Y;Dong W
通讯作者:
Dong W
影响因子:
158.5
作者:
Li, Qun;Guan, Xuhua;Feng, Zijian
通讯作者:
Feng, Zijian
影响因子:
11.1
作者:
Lu, Jing;Peng, Jinju;Ke, Changwen
通讯作者:
Ke, Changwen
影响因子:
13.8
作者:
Bellan M;Soddu D;Balbo PE;Baricich A;Zeppegno P;Avanzi GC;Baldon G;Bartolomei G;Battaglia M;Battistini S;Binda V;Borg M;Cantaluppi V;Castello LM;Clivati E;Cisari C;Costanzo M;Croce A;Cuneo D;De Benedittis C;De Vecchi S;Feggi A;Gai M;Gambaro E;Gattoni E;Gramaglia C;Grisafi L;Guerriero C;Hayden E;Jona A;Invernizzi M;Lorenzini L;Loreti L;Martelli M;Marzullo P;Matino E;Panero A;Parachini E;Patrucco F;Patti G;Pirovano A;Prosperini P;Quaglino R;Rigamonti C;Sainaghi PP;Vecchi C;Zecca E;Pirisi M
通讯作者:
Pirisi M